Evgo Inc. quarterly report, Q1 FY2021

Business context and reporting period

This is the unaudited Form 10-Q of Climate Change Crisis Real Impact I Acquisition Corporation (CRIS), a SPAC, for the quarter ended March 31, 2021—not an operating-company 10-Q for EVgo Inc. CRIS had not begun operations or generated revenue. It had signed a January 21, 2021 agreement to combine with EVgo, but the transaction was still pending at quarter-end.

Financial results and liquidity

MetricQuarter ended March 31, 2021
RevenueNone
Formation and operating costs$1.9 million
Change in fair value of warrant liability$29.0 million expense, non-cash
Net loss$30.9 million
Operating cash used$0.6 million
Cash outside Trust Account$0.4 million
Trust Account investments$230.0 million
Warrant liability$61.9 million

Interest income was approximately $3,500. The reported loss principally reflects the fair-value remeasurement of warrants, rather than operating performance. No operating margins are meaningful or reported. The filing reports no long-term debt; it separately discloses a $280,000 related-party promissory note issued March 31 to fund transaction expenses, bearing 0.12% annual interest and payable upon completion of the business combination. The $8.05 million deferred underwriting fee is payable only if a business combination closes.

Changes versus prior period

There is no comparable first-quarter 2020 operating period presented. Compared with December 31, 2020, the warrant liability rose from $32.8 million to $61.9 million, primarily driving the quarter’s non-cash loss. Trust Account investments were nearly unchanged; cash outside the Trust Account declined from $990,249 to $385,272. Class A shares classified as subject to possible redemption declined from 18.46 million to 15.37 million.

Transaction, outlook, risks and unusual items

  • The proposed EVgo transaction contemplated CRIS contributing Trust Account funds, PIPE proceeds and other available cash, net of redemptions and transaction expenses. The related PIPE commitments totaled $400 million for 40 million shares at $10 per share, contingent on closing; proceeds were intended for EVgo and its subsidiaries.
  • CRIS expected continued transaction and public-company costs, and stated it might need additional financing if costs exceeded estimates or redemptions were significant. There is no EVgo operating guidance in this filing.
  • CRIS had until October 2, 2022 to complete a business combination, subject to possible extension; otherwise it would liquidate and redeem public shares. Warrants could expire worthless if no transaction closed.
  • Disclosure controls were deemed ineffective because of a material weakness in warrant accounting. CRIS disclosed that it had concluded its 2020 financial statements should not be relied upon and planned remediation; it gave no assurance that remediation would be effective.
  • Management said COVID-19 could negatively affect CRIS’s financial position, results or search process, but the impact was not readily determinable. No material legal proceedings were reported.

Important facts for investors to verify

  1. Confirm transaction completion status, redemption levels, final cash delivered to EVgo and whether the $400 million PIPE funded.
  2. Review EVgo’s own operating-company filings for revenue, profitability, cash flow, debt, liquidity and outlook; CRIS’s figures above do not represent EVgo’s operating results.
  3. Assess the warrant valuation and control weakness, the 2020 restatement/non-reliance disclosure, and progress on remediation.
  4. Confirm treatment and repayment of the $280,000 related-party note, deferred underwriting fee and other transaction expenses at closing.